News for Oaktree Acquisition Corp. (OAC-UN)

On December 31, 2024, the Healthcare of Ontario Pension Plan Trust Fund executed a notable transaction by acquiring 1,700,000 shares of Oaktree Acquisition Corp

Alvotech (ALVO), a commercial-stage global biotech company specializing in the development and manufacture of biosimilar medicines, is making steady progress in its pipeline to drive future growth and diversification.

Oaktree Acquisition Corp. III Life Sciences (the ”œCompany”) today announced that, commencing December 16, 2024, holders of the units sold in the Company's

HIMS Stock Soars to All-Time High, Reaching $30.45

Oaktree Acquisition Corp. III Life Sciences Announces Pricing of $175 Million Initial Public Offering

Hims & Hers Health issues shares for Medisource acquisition

Alvotech has successfully commercialized two biosimilar drugs, with more in the pipeline. Click here to see why ALVO stock is a Buy.

Recent acquisitions and capital allocation decisions raise concerns about Diversified Energy's long-term value proposition. Read why I rate DEC stock a Hold now.

Alvotech Corporate Overview June 2024 Disclaimer This...

Hims & Hers aims to capitalize on the shortages of the branded drugs Wegovy and Zepbound. Read more to see why I'm bullish on HIMS stock.

SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar approval under the strategic partnership...

The study, which assessed the pharmacokinetics, safety, and tolerability of AVT03 compared to Prolia® in healthy adult subjects, met its primary endpointsProlia® and Xgeva® are indicated for the...

The study, assessing pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi® in healthy adult subjects, met its primary endpoint Alvotech , a global biotech company specializing in...

Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the US Food and Drug Administration has issued...

Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that Faysal Kalmoua has been appointed Alvotech’s...

GuruFocus Article or News written by insider and the topic is about:

Read Oaktree Acquisition Corp. II (NYSE:OACB) and Trepont Acquisition Corp I (NYSE:TACA) Head-To-Head Contrast at ETF Daily News

Read Research Analysts’ Downgrades for May 24th (AR, CLF, CTEK, DATWY, DHRPY, DLTR, DRXGF, EOG, ETN, FLWR) at ETF Daily News

Read Investment Analysts’ Upgrades for May 11th (ADDYY, AHT, ARCT, ARTNA, ARWR, ASHTY, AZEK, BNCDY, CELH, CLB) at ETF Daily News